Stefanie Hammer

2.9k total citations
63 papers, 2.1k citations indexed

About

Stefanie Hammer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Stefanie Hammer has authored 63 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Stefanie Hammer's work include Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Treatment and Research (10 papers) and Platelet Disorders and Treatments (8 papers). Stefanie Hammer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Treatment and Research (10 papers) and Platelet Disorders and Treatments (8 papers). Stefanie Hammer collaborates with scholars based in Germany, United States and Norway. Stefanie Hammer's co-authors include Kenneth K.W. To, Minori Koshiji, Eric Huang, Adrian L. Harris, Paul Modrich, Kensuke Kumamoto, Anette Sommer, Jens Hoffmann, Johannes Merk and Iduna Fichtner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Stefanie Hammer

62 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Hammer Germany 23 835 545 502 407 322 63 2.1k
Elizabeth L. Wiley United States 28 820 1.0× 682 1.3× 669 1.3× 252 0.6× 372 1.2× 93 2.4k
Bo Chen China 23 875 1.0× 758 1.4× 440 0.9× 162 0.4× 433 1.3× 114 1.9k
Antonia D’Errico Italy 29 712 0.9× 491 0.9× 418 0.8× 698 1.7× 326 1.0× 94 2.4k
Jing Jiang United States 29 846 1.0× 594 1.1× 325 0.6× 150 0.4× 457 1.4× 62 2.1k
David M. Kurtz United States 22 881 1.1× 697 1.3× 1.1k 2.2× 483 1.2× 500 1.6× 112 2.9k
Yasunobu Kanamori Japan 26 1.0k 1.2× 1.1k 2.0× 452 0.9× 245 0.6× 186 0.6× 72 2.5k
Clara Salas Spain 29 1.7k 2.0× 896 1.6× 330 0.7× 499 1.2× 474 1.5× 127 3.5k
Myrna Candelaria Mexico 25 1.4k 1.7× 563 1.0× 243 0.5× 299 0.7× 272 0.8× 88 2.5k
Taku Nakagawa Japan 28 888 1.1× 632 1.2× 419 0.8× 574 1.4× 519 1.6× 126 2.4k
Till Braunschweig Germany 33 1.1k 1.3× 583 1.1× 405 0.8× 161 0.4× 437 1.4× 124 2.7k

Countries citing papers authored by Stefanie Hammer

Since Specialization
Citations

This map shows the geographic impact of Stefanie Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Hammer more than expected).

Fields of papers citing papers by Stefanie Hammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Hammer. The network helps show where Stefanie Hammer may publish in the future.

Co-authorship network of co-authors of Stefanie Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Hammer. A scholar is included among the top collaborators of Stefanie Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Hammer. Stefanie Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Althaus, Karina, Stefanie Hammer, Nina Wolska, et al.. (2025). Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A. Blood Advances. 9(5). 1181–1184.
2.
Böhnke, Niels, Bård Indrevoll, Stefanie Hammer, et al.. (2023). Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models. European Journal of Nuclear Medicine and Molecular Imaging. 51(3). 669–680. 9 indexed citations
3.
Karlsson, Jenny, Christoph A. Schatz, Antje M. Wengner, et al.. (2023). Targeted thorium-227 conjugates as treatment options in oncology. Frontiers in Medicine. 9. 1071086–1071086. 17 indexed citations
4.
Uzun, Günalp, et al.. (2023). Diagnostic Performance of a Particle Gel Immunoassay in Vaccine-Induced Immune Thrombotic Thrombocytopenia. Hämostaseologie. 43(1). 22–27. 4 indexed citations
5.
Pelzl, Lisann, Anurag Singh, Irene Marini, et al.. (2021). Antibody‐mediated procoagulant platelet formation in COVID‐19 is AKT dependent. Journal of Thrombosis and Haemostasis. 20(2). 387–398. 21 indexed citations
6.
Lejeune, Pascale, Véronique Cruciani, Andreas Schlicker, et al.. (2021). Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy. Journal for ImmunoTherapy of Cancer. 9(10). e002387–e002387. 36 indexed citations
7.
Althaus, Karina, Irene Marini, Jan Zlamal, et al.. (2020). Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. 137(8). 1061–1071. 132 indexed citations
8.
Hammer, Stefanie, Urs B. Hagemann, Sabine Zitzmann-Kolbe, et al.. (2019). Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer. Clinical Cancer Research. 26(8). 1985–1996. 94 indexed citations
9.
Hartung, Ingo V., Roland Neuhaus, Arne Scholz, et al.. (2013). Optimization of allosteric MEK inhibitors. Part 1: Venturing into underexplored SAR territories. Bioorganic & Medicinal Chemistry Letters. 23(8). 2384–2390. 15 indexed citations
10.
Hammer, Stefanie, Anette Sommer, Iduna Fichtner, et al.. (2010). Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer. Clinical Cancer Research. 16(5). 1452–1465. 34 indexed citations
11.
Böhnke, Anja, Eleonora Leucci, Søren Jensby Nielsen, et al.. (2010). An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity. Cancer Research. 70(23). 9641–9649. 141 indexed citations
12.
Fichtner, Iduna, Jana Rolff, Richie Soong, et al.. (2008). Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers. Clinical Cancer Research. 14(20). 6456–6468. 227 indexed citations
13.
Schueler, Markus, Stefanie Hammer, Utz Johann Pape, et al.. (2008). Prediction of cardiac transcription networks based on molecular data and complex clinical phenotypes. Molecular BioSystems. 4(6). 589–598. 15 indexed citations
14.
Hammer, Stefanie, Martin Lange, Jenny J. Fischer, et al.. (2008). Characterization of TBX20 in human hearts and its regulation by TFAP2. Journal of Cellular Biochemistry. 104(3). 1022–1033. 49 indexed citations
15.
Hammer, Stefanie, et al.. (2007). Hypoxic Suppression of the Cell Cycle GeneCDC25Ain Tumor Cells. Cell Cycle. 6(15). 1919–1926. 49 indexed citations
16.
Radeke, Heinfried H., et al.. (2005). Overlapping Signaling Pathways of Sphingosine 1-Phosphate and TGF-β in the Murine Langerhans Cell Line XS52. The Journal of Immunology. 174(5). 2778–2786. 61 indexed citations
17.
Koshiji, Minori, Kenneth K.W. To, Stefanie Hammer, et al.. (2005). HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression. Molecular Cell. 17(6). 793–803. 279 indexed citations
18.
Hammer, Stefanie, et al.. (2004). Glucocorticoids mediate differential anti‐apoptotic effects in human fibroblasts and keratinocytes via sphingosine‐1‐phosphate formation. Journal of Cellular Biochemistry. 91(4). 840–851. 32 indexed citations
19.
Hammer, Stefanie, et al.. (2003). Transcriptional Activity of Potent Glucocorticoids: Relevance of Glucocorticoid Receptor Isoforms and Drug Metabolites. Skin Pharmacology and Physiology. 16(3). 143–150. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth L. Wiley Breakdown of academic impact, for papers by Bo Chen Breakdown of academic impact, for papers by Antonia D’Errico Breakdown of academic impact, for papers by Jing Jiang Breakdown of academic impact, for papers by David M. Kurtz Breakdown of academic impact, for papers by Yasunobu Kanamori Breakdown of academic impact, for papers by Clara Salas Breakdown of academic impact, for papers by Myrna Candelaria Breakdown of academic impact, for papers by Taku Nakagawa Breakdown of academic impact, for papers by Till Braunschweig
Rankless by CCL
2026